# PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain.

> **NCT06171243** · — · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 20 (actual)

## Conditions studied

- Neuralgia
- Neuropathic Pain
- Local Anesthetic Complication
- Lidocaine Adverse Reaction

## Interventions

- **DRUG:** Lidocaine topical

## Key facts

- **NCT ID:** NCT06171243
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-17
- **Primary completion:** 2024-09-23
- **Final completion:** 2025-07-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171243, "PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06171243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*